Bedford Pharmacy Recalls Hydroxocobalamin Injection Due to Sterility Concerns
Bedford Pharmacy is recalling Hydroxocobalamin 20 mg/mL Injection due to a lack of assurance of sterility. The product was distributed in New Hampshire and Massachusetts.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. According to the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly when involving potential health consequences such as sterility issues in injectable drugs.
Plain-English summary
Bedford Pharmacy is recalling Hydroxocobalamin 20 mg/mL Injection, 1 vial, due to a lack of assurance of sterility. The recall involves Lot # 08042015@3 with an expiration date of 09/18/2015.
The product was distributed in New Hampshire and Massachusetts. The FDA has classified this recall as Class II, which indicates that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers and healthcare providers should stop using the recalled product and contact Bedford Pharmacy at (603) 472-3919 for further instructions or a return.
The recalled product
- Product
- Hydroxocobalamin 20 mg/mL Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919
- Manufacturer
- Bedford Pharmacy
- Category
- Drug — Injection
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 08042015@3
- Exp 09/18/2015
Distribution
Part of a larger recall action
This product is one of 13 recalled by Bedford Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · Bedford Pharmacy
See all →- HighBedford Pharmacy Recalls P-P-P Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P-P Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P (COBAL) Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P (COBAL) Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P (COBAL) Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29